Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ultragenyx Pharmaceu (RARE)

Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,886,558
  • Shares Outstanding, K 83,133
  • Annual Sales, $ 434,250 K
  • Annual Income, $ -606,640 K
  • 60-Month Beta 0.56
  • Price/Sales 12.25
  • Price/Cash Flow N/A
  • Price/Book 12.65
Trade RARE with:

Options Overview Details

View History
  • Implied Volatility 62.81% ( -1.14%)
  • Historical Volatility 29.10%
  • IV Percentile 76%
  • IV Rank 36.92%
  • IV High 110.63% on 04/12/24
  • IV Low 34.83% on 12/22/23
  • Put/Call Vol Ratio 0.15
  • Today's Volume 625
  • Volume Avg (30-Day) 446
  • Put/Call OI Ratio 0.43
  • Today's Open Interest 15,692
  • Open Int (30-Day) 12,989

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -1.42
  • Number of Estimates 11
  • High Estimate -1.14
  • Low Estimate -1.62
  • Prior Year -2.23
  • Growth Rate Est. (year over year) +36.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.63 +11.69%
on 08/20/24
60.37 -2.63%
on 09/16/24
+5.00 (+9.30%)
since 08/19/24
3-Month
37.27 +57.71%
on 06/20/24
60.37 -2.63%
on 09/16/24
+21.36 (+57.08%)
since 06/18/24
52-Week
31.52 +86.48%
on 10/24/23
60.37 -2.63%
on 09/16/24
+22.39 (+61.53%)
since 09/19/23

Most Recent Stories

More News
Ultragenyx: Q2 Earnings Snapshot

Ultragenyx: Q2 Earnings Snapshot

RARE : 58.78 (+1.87%)
1 Biotech Stock to Buy for 104% Upside Potential

Ultragenyx Pharmaceuticals is a beaten-down biotech stock trading at a steep discount to consensus price target estimates.

RARE : 58.78 (+1.87%)
GS : 503.83 (+3.97%)
Ultragenyx: Q1 Earnings Snapshot

Ultragenyx: Q1 Earnings Snapshot

RARE : 58.78 (+1.87%)
Ultragenyx: Q4 Earnings Snapshot

Ultragenyx: Q4 Earnings Snapshot

RARE : 58.78 (+1.87%)
Ultragenyx: Q3 Earnings Snapshot

Ultragenyx: Q3 Earnings Snapshot

RARE : 58.78 (+1.87%)
Ultragenyx: Q2 Earnings Snapshot

Ultragenyx: Q2 Earnings Snapshot

RARE : 58.78 (+1.87%)
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside.

DNLI : 31.05 (+0.94%)
RARE : 58.78 (+1.87%)
SRPT : 127.10 (+1.67%)
PFE : 29.66 (-0.30%)
EXEL : 26.83 (+0.04%)
MRNA : 68.02 (-2.63%)
UTHR : 351.33 (+2.55%)
BIIB : 201.44 (+1.95%)
SNY : 58.26 (+1.37%)
LLY : 915.04 (+1.11%)
Ultragenyx: Q1 Earnings Snapshot

Ultragenyx: Q1 Earnings Snapshot

RARE : 58.78 (+1.87%)
Ultragenyx: Q4 Earnings Snapshot

Ultragenyx: Q4 Earnings Snapshot

RARE : 58.78 (+1.87%)
Ultragenyx: Q3 Earnings Snapshot

Ultragenyx: Q3 Earnings Snapshot

RARE : 58.78 (+1.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Ultragenyx Pharmaceutical Inc. is focused on the identification, acquisition, development and commercialization of novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases.

See More

Key Turning Points

3rd Resistance Point 61.41
2nd Resistance Point 60.65
1st Resistance Point 59.72
Last Price 58.78
1st Support Level 58.03
2nd Support Level 57.27
3rd Support Level 56.34

See More

52-Week High 60.37
Last Price 58.78
Fibonacci 61.8% 49.35
Fibonacci 50% 45.94
Fibonacci 38.2% 42.54
52-Week Low 31.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar